TSX Declines as Investors Await Tariff Decisions

Canada's main stock index faced a decline on Wednesday, pressured by losses in the technology sector and uncertainty surrounding upcoming U.S. tariffs. The TSX Composite Index fell 85.71 points to 25,253.80, while the Canadian dollar slightly increased to 70.18 cents U.S. In corporate news, Theratechnologies received FDA approval for a new treatment for HIV patients, leading to a significant rise in its share price. The NASDAQ also experienced a drop of 303.67 points, reflecting broader market concerns as investors await clarity on trade policy and economic indicators. Meanwhile, the U.S. market showed signs of temporary relief following President Trump's indication that not all tariffs would take effect as initially planned, although details remain unclear. Overall, the markets are navigating a complex landscape of potential economic impacts stemming from trade tensions and consumer confidence declines.